Publicacións nas que colabora con Tomas García-Caballero Parada (10)

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer? (Virchows Archiv, (2021), 479, 4, (853-857), 10.1007/s00428-021-03104-7)

    Virchows Archiv

  2. Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

    Virchows Archiv, Vol. 479, Núm. 4, pp. 853-857

2020

  1. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: Efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

    Breast Cancer: Targets and Therapy, Vol. 11, pp. 29-42

2017

  1. Liver metastasis is facilitated by the adherence of circulating tumor cells to vascular fibronectin deposits

    Cancer Research, Vol. 77, Núm. 13, pp. 3431-3441

2016

  1. Ki-67 is a prognostic marker for hormone receptor positive tumors

    Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 996-1002

  2. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

    Scientific Reports, Vol. 6

2015

  1. M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis

    Journal of the National Cancer Institute, Vol. 107, Núm. 9

  2. Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment

    Oncotarget, Vol. 6, Núm. 16, pp. 14456-14471